The Genius Academy Automation: Work Smarter, Not Harder
DALLAS, TX / ACCESSWIRE / June 15, 2021 / Many investors will tell you that…
DALLAS, TX / ACCESSWIRE / June 15, 2021 / Many investors will tell you that…
Phase 0 trial in ARDS subjects estimated completion by end of 1st QTR 2022FDA indicates…
NORCROSS, GA / ACCESSWIRE / June 15, 2021 / Success is nothing new for the…
CALGARY, AB / ACCESSWIRE / June 15, 2021 / Perisson Petroleum Corp. (the ‘Corporation‘) (TSXV:POG)…
Uplisting to a National Exchange is the Company’s Objective COSTA MESA, CA / ACCESSWIRE /…
FAYETTEVILLE, AR / ACCESSWIRE / June 15, 2021 / Independent film distributor Hannover House, Inc….
Monthly information regarding the total number of voting rights and total number of shares of…
Monthly information regarding the total number of voting rights and total number of shares of…
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
Quorum of 18.19% on first convening Combined Shareholders Meeting will be reconvened on June 30,…
Quorum of 18.19% on first convening Combined Shareholders Meeting will be reconvened on June 30,…
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced…
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced…
TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus”…
TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus”…
Additional Follow-up of First 20 Adult Patients Enrolled Continues to Show Encouraging Efficacy and Tolerability…
Additional Follow-up of First 20 Adult Patients Enrolled Continues to Show Encouraging Efficacy and Tolerability…
Expands Eton’s Adrenal Insufficiency Orphan Drug Portfolio ZENEO® Hydrocortisone is Expected to be the First…
Expands Eton’s Adrenal Insufficiency Orphan Drug Portfolio ZENEO® Hydrocortisone is Expected to be the First…